Thomson Medical Group's (SGX:A50) Malaysia-listed unit, TMC Life Sciences (KLSE:TMCLIFE), appointed Ahmad Adzuan Abdul Rahman as group chief executive officer.
Rahman takes over the role from Melvin Heng Jun Li, who has been redesignated from acting group CEO to non-executive director, according to a Monday filing with the Singapore Exchange.
Before joining TMC Life, Rahman was a founding member and advisor of Novotec Group. Prior to that, he was a regional managing director and executive vice president at IDS Medical Systems.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。